SEC Form 4 · accession 0001013606-19-000017
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Onopchenko
Officer — CEO and Director · Director
Period of report
Dec 30, 2018
Accepted (ET)
Jan 2, 2019 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 30, 2018 | A | 604,433 | $0.00 | A | 661,037 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The time-based restricted stock unit award shall vest in three equal annual installments on May 2, 2019, May 2, 2020 and May 2, 2021 and shall settle in shares of common stock on each of those dates.